UNSPSC 51101933: Mepacrine

This classification denotes an antiprotozoal agent and antineoplastic with the molecular formula C23H30ClN3O.2ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G6242H2NAA, chemically known as 1,4-pentanediamine, n4- (6-chloro-2-methoxy-9-acridinyl)-n1,n1-diethyl-, dihydrochloride but generally known as mepacrine hydrochloride, which bears US NIH Compound Identifier 237. European Medicines Agency schedules Mepacrine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03152MIG.

Most nations schedule mepacrine under HS 29339990 and SITC 51577. SMILES: Clc1cc2nc3c(c(NC(CCCN(CC)CC)C)c2cc1)cc(OC)cc3.

UNSPSC 51101933 Mepacrine, a Commodity code, does not reflect the work actually being solicited under it in recent state and local procurement. The code's nominal scope addresses a specific antimalarial pharmaceutical, but the recent opportunities tagged to this code document solicitations for naloxone, safe drug deactivation systems, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products. State and local procurement offices are using this code to classify pharmaceutical and medical supply acquisitions far broader than mepacrine itself—covering emergency response consumables, pharmacy benefit program infrastructure, and large-scale generic drug procurement through cooperative purchasing vehicles. The issuing bodies span state health and human services departments, county public health authorities, city fire departments, and multistate cooperative purchasing alliances, indicating the code captures health-sector procurement across jurisdictional types.

Recent activity appears in Florida, Texas, and Minnesota-led cooperative purchasing. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023, an apparent date error in the source) for 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. The Texas Health and Human Services Commission issued an RFI on April 3, 2026 seeking vendor capabilities for a direct-to-manufacturer prescription program outside traditional PBM channels. The City of Tampa released an IFB on March 25, 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, a $700,000 procurement restricted to certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract effectiveness July 1, 2026. The code shows material recent activity but carries taxonomy misalignment—mepacrine is not the primary work being bought.